Loading...

Molecular Partners AG

MLLCFPNK
Healthcare
Biotechnology
$2.50
$0.00(0.00%)
U.S. Market opens in 3h 19m

Molecular Partners AG (MLLCF) Stock Competitors & Peer Comparison

See (MLLCF) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
MLLCF$2.50+0.00%93.5M-1.19-$2.10N/A
NONOF$39.94+3.42%177.7B11.02$3.63+4.58%
CSLLY$23.15+1.31%89.8B15.06$1.54+3.15%
UCBJF$291.41-1.73%55.5B30.77$9.47+0.54%
UCBJY$140.30-2.28%53.7B29.73$4.74+0.56%
ARGNF$781.00-3.71%49.4B40.84$19.55N/A
CMXHF$91.73-0.71%44.5B14.87$6.17+3.18%
WXIBF$4.70+2.17%19.4B27.65$0.17N/A
IVBXF$10.29+0.00%17.7B147.00$0.07N/A
WXXWY$8.63+0.94%17.7B25.12$0.34N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

MLLCF vs NONOF Comparison April 2026

MLLCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLLCF stands at 93.5M. In comparison, NONOF has a market cap of 177.7B. Regarding current trading prices, MLLCF is priced at $2.50, while NONOF trades at $39.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLLCF currently has a P/E ratio of -1.19, whereas NONOF's P/E ratio is 11.02. In terms of profitability, MLLCF's ROE is -0.60%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, MLLCF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for MLLCF.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions